Articles

Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300

Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich
Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich
Bioinformatics Research Unit, Riga Stradins University, Riga, Latvia; netOmics, Riga
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich
Bone Lab Dresden, Department of Medicine III and Center for Healthy Aging, Technische Universitaet Dresden, Dresden
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology-Oncology, Munich
Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; School of Medicine, Institute of Clinical Chemistry and Pathobiochemistry, Technical University of Munich, Munich
Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, Munich
Bone Lab Dresden, Department of Medicine III and Center for Healthy Aging, Technische Universitaet Dresden, Dresden
Max Planck Institute of Molecular Cell Biology and Genetics, Transgenic Core Facility
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg
Technical University of Munich, School of Medicine, Center for Translational Cancer Research (TranslaTUM), 81675 Munich, Germany; Technical University of Munich, School of Medicine, Institute of Molecular Oncology and Functional Genomics, 81675 Munich, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich, Germany; Current address: Technical University of Munich, School of Medicine, Surgery Department, 81675 Munich
Technical University of Munich, School of Medicine, Department of Internal Medicine III Hematology/Oncology, 81675 Munich
Haematologica Early view Aug 11, 2022 https://doi.org/10.3324/haematol.2022.280760